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Abstract
Mammalian cells can choose either nonhomologous end joining (NHEJ) or homologous
recombination (HR) for repair of chromosome breaks. Of these two pathways, HR alone requires
extensive DNA synthesis and thus abundant synthesis precursors (dNTPs). We address here if this
differing requirement for dNTPs helps determine how cells choose a repair pathway. Cellular dNTP
pools are regulated primarily by changes in ribonucleotide reductase activity. We show that an
inhibitor of ribonucleotide reductase (hydroxyurea) hypersensitizes NHEJ-deficient cells, but not
wild type or HR-deficient cells, to chromosome breaks introduced by ionizing radiation.
Hydroxyurea additionally reduces the frequency of irradiated cells with a marker for an early step
in HR, Rad51 foci, consistent with reduced initiation of HR under these conditions. Conversely,
promotion of ribonucleotide reductase activity protects NHEJ-deficient cells from ionizing radiation.
Importantly, promotion of ribonucleotide reductase activity also increases usage of HR in cells
proficient in both NHEJ and HR at a targeted chromosome break. Activity of ribonucleotide reductase
is thus an important factor in determining how mammalian cells repair broken chromosomes. This
may explain in part why G1/G0 cells, which have reduced ribonucleotide reductase activity, rely
more on NHEJ for DSB repair.
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2. Introduction
Efficient and accurate repair of DNA double strand breaks (DSBs) is essential for cell survival.
Eukaryotic cells employ two major pathways for DSB repair: nonhomologous endjoining
(NHEJ) and homologous recombination (HR) (reviewed in [1]). NHEJ religates broken ends
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with minimal or no requirement for DNA synthesis, and is active during the whole cell cycle
[2–6]. In contrast, HR has extensive requirements for DNA synthesis and is primarily employed
for DSB repair in S and G2 phases [3–6]. A key step in HR, and the point where cells commit
to repair by HR over repair by NHEJ [6,7], involves resection of 100s to 1000s of nucleotides
from 5′-ends to produce long single stranded 3′-overhangs. These 3′-overhangs then invade
the sister chromatid or homologous chromosome and serve as primers for re-synthesis of the
previously degraded sequence around the break (reviewed in [8]). HR’s need for extensive
DNA synthesis suggests it will be much more dependent than NHEJ on the presence of
sufficient dNTPs.
Availability of dNTPs is primarily reliant on the de novo pathway and specifically activity of
ribonucleotide reductase (RNR). RNR activity has been additionally linked to the cellular
capacity to survive DNA damage [9,10]. RNR possesses a large subunit (R1) and one of two
possible small subunits (R2 or p53R2) [11]. RNR activity is regulated over the cell cycle by
limiting transcription of the primary version of the small subunit, R2, to S and G2 [12], as well
as destruction of this protein in M phase [13]. As a consequence, RNR activity rises in early
S, and falls after G2 – a fluctuation that correlates well with the extent cells perform HR.
Cells nevertheless retain some ability to generate nucleotide pools de novo in G1 by using a
complex of R1 and the alternative version of the small subunit, p53R2 [14]. P53R2 is expressed
at low levels throughout the cell cycle [15], but expression can be further augmented after DNA
damage through a p53-dependent mechanism [16]. p53R2 protein is additionally stabilized
after DNA damage through an ataxia telangiectasia mutated (ATM) dependent mechanism
[17]. This up-regulation and stabilization after DNA damage is consistent with a specific role
for p53R2 in providing nucleotides for DNA repair [14].
Here we address whether manipulation of cellular capacity to generate dNTPs de novo by RNR
has an impact on whether cells repair chromosome breaks by HR or by NHEJ. We show that
treatment with hydroxyurea (HU), which inhibits RNR activity, suppresses HR; conversely,
stimulation of nucleotide synthesis promotes HR. We conclude that de novo nucleotide
production is an important determinant of repair pathway choice.
3. Materials and Methods
3.1. Cell culture and colony formation assays
All cell lines were grown at 37°C and 5% CO2 in DMEM (Gibco) supplemented with 10%
fetal bovine serum (Gibco), 1x MEM non-essential amino acids (Gibco), penicillin, and
streptomycin. The Brca2−/− cell line (V-C8) and the matching parental line (V79) was the kind
gift of Dr. M.Z. Zdzienicka. Cells were synchronized essentially as previously described [4],
except that cells were grown in presence of 5 mM N-acetyl-cysteine (Sigma) and 10 mM
HEPES (Gibco) for synchronization in G1/G0. For enrichment in G1/G0, 8×104 cells/cm2 were
plated out and grown to confluency during 3 days. For enrichment in S phase, G1/G0 cells
were replated at a density of 4×104/cm2, incubated for 16 hours in the presence of aphidicolin
(1 μg/ml, Sigma), and released by medium change. 3 hours after release (3.5 hours for HR-
deficient cell line irs1SF), the majority of the cells reached mid-S phase. Synchronization was
verified by analysis of cell cycle profiles by flow cytometry (Dako Cyan ADP) after propidium
iodide staining (Roche). Only experiments with at least 80% pure populations were analyzed
(e.g. supplemental Figure 1).
Xrs6 was complemented by generating a subclone that stably integrated a cDNA containing
the C. griseus gene encoding Ku80 (the kind gift of Dr. D.B. Roth) and that was grown in
presence of 400 μg/ml Geneticin (Invitrogen). In order to measure repair by homologous
recombination, pDR-GFP [18] (the kind gift of Dr. M. Jasin) was stably integrated into the
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Chinese hamster ovary (CHO) cell line K1, resulting in the cell line K-DR, which was grown
in presence of 10 μg/ml puromycin (Sigma). The murine gene encoding p53R2 was inserted
into pcDNA6/myc-His A (Invitrogen) and stably integrated into the CHO cell lines K1 and
Xrs6, resulting in lines K+P and X+P. p53R2 overexpressing lines were grown in presence of
10 μg/ml blasticidin (Invitrogen). Expression of myc-tagged p53R2 was verified by western
blot with the monoclonal mouse antibody 9B11 (Cell Signaling). An actin-specific polyclonal
rabbit antibody (A2066; Sigma) was used for the loading control.
For colony formation assays, synchronized cells were plated out in presence or absence of 0.2
mM hydroxyurea or 1 μg/ml aphidicolin (both Sigma). After one hour, cells were irradiated
with 1 Gy in a Gammacell 40 irradiator (137Cs). 7 hours after irradiation cells were washed
with 1x phosphate buffered saline (PBS) and provided with fresh medium without drug. The
number of colonies was assessed 7 days later by Comassie staining (50% methanol, 5%
Comassie) and counted using ImageJ (NIH) as software. All experiments were repeated at least
3 times, and the mean and standard error of the mean for each experiment were calculated with
Prism 4.0c (Graphpad).
3.2. Repair substrate assay
1×106 exponentially growing wild type CHO cells containing the recombination substrate DR-
GFP, K-DR, were transfected with 2 μg plasmid DNA (Amaxa, Kit T (VCA-1002), program
H-014): empty vector alone (pcDNA6/LacZ-myc) in combination with expression vectors for
p53R2 or p53R2-Y138V, a catalytic mutant, respectively. In parallel reactions, expression
vectors for I-SceI and p53R2 or p53R2-Y138V, respectively, were delivered by
electroporation. GFP expression was analyzed by flow cytometry 48 hours later. All
experiments were repeated 3 times and means as well as standard errors of the mean were
calculated with Prism 4.0c (Graphpad).
3.3. Immunofluorescence
G1/G0 or S phase enriched cells were seeded onto collagen-coated coverslips (Becton-
Dickinson) in medium containing 0.2 mM hydroxyurea, 1 μg/ml aphidicolin, or no drug. Cells
were irradiated one hour later with 8 Gy. Cells were then fixed with 4% buffered
paraformaldehyde in PBS at indicated times; no apoptotic cells could be detected up to 10
hours after irradiation (Supplemental Figure 2). Fixed cells were then permeabilized with 0.2%
Triton X-100 for 3 minutes and analyzed with primary antibodies (Santa Cruz; catalogue
numbers and dilutions noted for each antibody in parenthesis) against R2 (sc-10848; 1:200),
Rad51 (sc-8349; 1:150), and Cyclin A (sc-751; 1:100) and secondary antibodies Alexa Fluor
488 conjugated donkey anti-goat (Molecular Probes; 1:1000) or Cy3 conjugated donkey anti-
rabbit (Jackson ImmunoResearch; 1:1000). After three washing steps with PBS, whereof the
first contained DAPI (5 μg/ml), coverslips were mounted onto glass slides with Fluorescent
Mounting Medium (DakoCytomation). Specimens were analyzed in an AxioScope II (Zeiss)
using a 40x objective and Openlab software. At least 100 cells were analyzed for each condition
and experiments were repeated at least three times. Cells with ≥3 Rad51 foci were considered
to be focus-positive. The mean and standard error of the mean was calculated with Prism 4.0c
as software.
4. RESULTS
4.1. Nucleotide synthesis influences survival after damage
We first tested whether inhibition of nucleotide synthesis impairs cell survival after ionizing
radiation (IR) in a pattern consistent with HR’s requirement for extensive DNA synthesis. For
this analysis we varied the ability of cells to use the two pathways by making use of well-
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established Chinese hamster cell lines with mutations in various genes essential for efficient
HR or NHEJ.
We manipulated the cellular ability to synthesize dNTPs by treating cells with hydroxyurea
(HU), which specifically blocks production of nucleotides de novo through inhibition of the
enzyme ribonucleotide reductase (RNR) [11,16]. In order to focus on the impact of HU on
repair of radiation-induced breaks we targeted G1/G0 enriched cells, so that HU alone could
not introduce damage (e.g. during replication). We also limited both the amounts of HU used
(200μM; 5–10 fold less than used in most protocols) as well as the contact time to the hour
immediately prior to irradiation and the additional 7 hours following. Cells were then washed
extensively and returned to normal growth conditions. The frequency of cells that survive this
treatment was determined by assessing their capacity to form colonies relative to untreated
controls (Table 1). To further summarize this data and focus on the impact of genotype, we
then additionally compared surviving fractions for each deficient cell line to its parental line
(Figure 1).
G1/G0 enriched cells deficient in HR (irs1SF and V-C8) [19,20] were not significantly sensitive
to 1 Gray (Gy) of IR (Table 1A,Figure 1A), relative to matched wild type controls (AA8 and
V79, respectively). This result is consistent with prior studies indicating that in G1/G0, IR-
induced breaks are primarily repaired by NHEJ [3–5]. However, we were able to detect
significant radiosensitivity in G1/G0-enriched V-C8 cells at higher doses (5 Gy; data not
shown). Critically, our data indicated neither wild type nor HR-deficient cells were made
significantly more radiosensitive at either dose when also treated with HU (Table 1A; Figure
1A). We conclude that blocking the ability to generate dNTPs de novo does not significantly
impact how well NHEJ proficient, G1/G0 enriched cells repair IR-generated DSBs, consistent
with our predictions.
In contrast, HU treatment significantly increased the radiation sensitivity of G1/G0 enriched
cells deficient in NHEJ (Xrs6 and XR-1 [21,22]; Table 1A, Figure 1A). Survival of NHEJ-
deficient cells was impaired after exposure to 1 Gy of IR, but survival was an additional ~5
fold lower if also treated with HU (Table 1A, p<0.05, Student’s T-test). The behavior of Xrs6
cells complemented with a Ku80 cDNA was indistinguishable from the parental line (K1),
confirming that these effects can be attributed to deficiency in the NHEJ component Ku80
(Table 1A, Figure 1A). HU treatment thus radiosensitizes NHEJ-deficient cells, but has little
to no impact on radiosensitivity of wild type cell lines or an HR-deficient cell line. We also
observed similar effects with the polymerase α/δ inhibitor aphidicolin (APH; Table 1A, Figure
1A), arguing for a general requirement for processive DNA synthesis if NHEJ deficient, G1/
G0 cells are to survive IR.
We also analyzed the impact of HU treatment after irradiation during S phase. Even though
cells are undergoing DNA replication at the time of treatment (Table 1B, Figure 1B), HU
treatment alone still has only mild effects on colony formation of wild type or HR deficient
cells. As previously reported, HR-deficient cells are sensitive to irradiation during S phase
[3,4]. However, further treatment with HU had an only modest additive impact on survival
(Table 1B), similar to that observed in wild type cells (Figure 1B).
Survival of NHEJ-deficient cells is slightly reduced after treatment with HU alone during S
phase (reduced by a factor of 2, relative to wild type cells; Table 1B). Nevertheless, HU reduced
survival by an additional 20 fold relative to that observed by IR alone in these cells (Xrs6;
Figure 1B). This effect is considerably greater than what would be expected if effects of the
two treatments were additive, as is the result in wild type cells. The ability to generate dNTPs
de novo may thus be critical for radioresistance in NHEJ deficient cells during S phase as well
as during G1.
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4.2. Hydroxyurea treatment inhibits early steps of HR
We suggest radioresistance in NHEJ deficient cells is 1) best attributed to successful repair by
HR, even in G1, and 2) that HR’s ability to repair DSBs is compromised by blocking de
novo nucleotide production. To more directly address this issue we followed formation of
Rad51 foci, an early marker for attempted DSB repair by HR, by immunofluorescence. Once
again, we note HU alone is sufficient to induce damage as well as Rad51 foci in S phase cells
(e.g. supplemental Figure 3) [23,24] and therefore focused again on G1/G0 enriched cells. To
exclude any contribution from possible contaminating S/G2 cells we also co-stained cells with
an antibody to a marker for S/G2 cells. We used the RNR subunit R2 as an S/G2 marker after
first confirming R2-positive cells correlated well with cells positive for Cyclin A, another
marker for cells in S/G2 (Figure 2A).
We assessed Rad51 focus formation in G1/G0 enriched K1 and Xrs6 cells after irradiation with
8 Gy (Figure 2B, C, and D). Rad51 focus-positive cells were apparent in Xrs6 cells but not K1
cells, indicating HR is employed for DSB repair in G1 cells only when NHEJ is not available
(Figure 2C) [25]. Importantly, HU treatment reduced radiation-dependent Rad51 foci 4.6 fold
in Xrs6 cells. This latter result is consistent with the attribution of HU’s ability to radiosensitize
these cells to reduced attempts at HR. Moreover, Rad51 focus formation is an early step in HR,
and precedes synthesis-dependent steps [26]. Inhibition of Rad51 focus formation under these
conditions suggests capacity to provide nucleotides for repair might help control whether cells
commit to HR. Also consistent with this suggestion, HU treatment (and presumably HU’s
ability to inhibit de novo nucleotide formation) was more effective in suppressing Rad51 foci
than was inhibition of DNA synthesis per se (through aphidicolin treatment; Figure 2D).
4.3. Overexpression of p53R2 promotes efficiency of HR
The results obtained after HU treatment are in line with our hypothesis that inhibition of RNR,
and thus a reduced capacity to provide dNTPs for repair, prevents use of HR. However, it
remains formally possible that the effects of HU treatment described above are independent of
HU’s ability to inhibit RNR. Moreover, we also wanted to test whether increased RNR activity
had the opposite effect. We therefore stably overexpressed a myc-tagged version of p53R2 in
both KU80-deficient cells (Xrs6) and the matched wild type parental line (K1; Figure 3A). We
confirmed this was sufficient to significantly impact whole cell dNTP pools during G1/G0,
though not in S phase (supplemental Figure 4), presumably because the primary small subunit
(R2) is present at high levels in S phase but not G1.
We irradiated cells that were enriched in either G1/G0 or S phase, and analyzed colony
formation as before (Figure 3B, and C). Importantly, overexpression of p53R2 protected NHEJ
deficient cells (X+P) from IR (Figure 3B). Survival improved 2.9-fold after irradiation in G1
and 6.6-fold in S phase, respectively (p<0.0001, Student’s T-test). The protective effect of
p53R2 overexpression was thus most evident in S phase, despite our observation that p53R2
overexpression did little to impact S phase whole-cell dNTP pools. Finally, p53R2 had little
impact on the radiosensitivity of wild type (K1) cells regardless of when in the cell cycle these
cells were irradiated (Figure 3C). We suggest this is because proficiency in both pathways in
wild type cells means differences in RNR activity does not significantly determine if cells
successfully repair double strand breaks, only which pathway (HR or NHEJ) they use to repair
them.
To determine if repair pathway choice in wild type cells is influenced by RNR activity, we
assessed repair more directly with the well-characterized recombination reporter construct,
DR-GFP. DR-GFP contains a recognition site for the homing endonuclease I-SceI within a
defective GFP gene (Figure 4A) [18]. Expression of I-SceI generates a double strand break
that can be repaired by a downstream homologous donor sequence, and this version of HR
Burkhalter et al. Page 5













repair can be quantitatively assessed by GFP expression (Figure 4 and supplemental Figure 5).
We stably integrated DR-GFP in wild type (K1) cells, thereby constructing the cell line K-DR,
and induced recombination by transient expression of I-SceI. RNR activity was varied by
additionally co-transfecting empty vector, or vectors that promote expression of either wild
type p53R2 or a catalytically inactive p53R2 point mutant (p53R2-Y138V; [27] and references
therein).
We observe that the marker for HR, GFP expression, accumulates 3 fold more efficiently in
clones that transiently overexpress wild type p53R2 than in the parental DR-GFP containing
line (Figure 4B). Contrastingly, overexpression of the catalytic mutant p53R2-Y138V did not
stimulate GFP expression. Since K-DR cells are proficient in both NHEJ and HR we conclude
overexpression of p53R2, and thus increased capacity for de novo dNTP synthesis, promotes
the use of HR over NHEJ for repair of DSBs.
5. DISCUSSION
In this work we identify RNR activity, and thus the capacity for generation of nucleotides de
novo, as an important determinant for whether cells can use HR to survive chromosome breaks
made by ionizing radiation. By comparison, manipulation of the de novo pathway (either
inhibition or promotion) had no significant impact on whether cells could similarly use NHEJ
to repair these breaks. NHEJ’s ability to sustain efficient repair regardless of the activity of the
de novo pathway is thus a strong rationale for using a repair pathway suggested to be
intrinsically more error prone than the alternative (HR).
It is notable that manipulation of RNR activity, and p53R2-dependent RNR activity in
particular, has an impact on DSB repair by HR that might be considered to exceed the expected
impact of these manipulations on whole cell dNTP pools. We demonstrated HU has a clear
effect on radiation sensitivity in G1, even though the effects of HU on whole cell pools in G1
cells are probably modest (unpublished data and [15,28,29]). Similarly, overexpression of
p53R2 protects S phase cells from ionizing radiation, yet we observe no obvious impact on
whole cell dNTP pools (Supplemental Figure 4). These observations parallel prior work
indicating replication is arrested in mammalian cells by inhibition of RNR, even when dNTP
pools are only subtly reduced [28,30]. As with replication, there are many reasons why changes
in RNR activity might have an impact on HR that appears to exceed its impact on whole cell
pools (see e.g. [29], and references therein). In this regard, reports that DNA damage both
stabilizes and relocalizes p53R2 to the nucleus [14,17], is consistent with the possibility that
p53R2 could contribute to a privileged or locally restricted pool that promotes efficient HR.
However, we note that damage-dependent relocalization is not universally observed [31].
We observed very different effects of HU on Rad51 foci depending on cell-cycle phase.
Consistent with our hypothesis, HU inhibits formation of radiation-induced Rad51 foci in G1
(Figure 2): in contrast, HU is sufficient for formation of Rad51 foci in S phase cells (e.g.
supplementary Figure 3). In S phase cells, HU treatment results in fork stalling but, as noted
above, dNTP pools are only subtly reduced (~2 fold; [28,30]). Therefore, S phase pools in
mammalian cells even after HU treatment are still much higher than would be present normally
in G1/G0, and this could explain how HR in HU-treated S phase cells remains active.
The choice of DSB repair pathway is primarily coupled to cell cycle through control of
resection, the first step in HR, by activity of S-CDK [6,7,32–34]. However, we note that at
least in mammalian cells, NHEJ is frequently used for DSB repair during S/G2 [3–5]. HR can
also be used for DSB repair in G1/G0 cells [25,35], particularly when NHEJ is blocked (Figures
1 and 2). These exceptions imply resection and thus the choice of DSB repair pathway may be
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regulated by factors in addition to S-CDK. We suggest activity of the RNR complex is a logical
candidate for such an additional factor (Figure 4C).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Sensitivity to ionizing radiation. Results from colony survival assays obtained with mutant cell
lines were compared to their corresponding parental line (irs1SF to AA8; V-C8 to V79; Xrs6,
XR-1, and Xrs6 complemented to K1). Bars thus represent the impact of the mutation on
sensitivity to irradiation and/or drug treatment for (A) G1/G0 or (B) S phase enriched cells.
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Analysis of Rad51 focus formation by immunofluorescence. (A) Representative
immunofluorescence data for cells co-stained for Cyclin A and R2; shown are S phase enriched
Xrs6 cells. (B) Representative immunofluorescence data for cells co-stained for Rad51 and the
R2 subunit of ribonucleotide reductase, a marker for S phase cells. Shown are Xrs6 cells after
irradiation with 8 Gy. (C) Mean frequency of Rad51 focus formation in R2-negative, G1/G0
cells from three independent experiments. Shown is the mean +/− SEM. **Ionizing radiation
significantly stimulated formation of Rad51 foci in Xrs6 cells; p=0.0014. (D) Quantification
of Rad51 focus formation in R2-negative, G1 phase Xrs6 cells at different time points after
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irradiation and in dependence of pretreatment with hydroxyurea (200μM) or aphidicolin (1
μg/ml). Shown is the mean +/−SEM from three independent experiments.
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Effect of p53R2 overexpression on cell survival. (A) Characterization of p53R2 overexpressing
CHO cell lines. Cell lysates of wild type (K1) and NHEJ-deficient (Xrs6) cells as well as myc-
p53R2 overexpressing subclones of these cell lines (K+P, X+P) were probed for myc or actin
in parallel Western blots. (B) Mean of three experiments comparing the frequency of survival
for the NHEJ-deficient cell lines (Xrs6) after irradiation with 1 Gy relative to un-irradiated
controls. Shown is mean +/− SEM. ***p53R2 overexpression made NHEJ-deficient cells
significantly radioresistant; p<0.0001. (C) Mean of three experiments comparing the frequency
of survival for the wild type CHO cell lines (K1) after irradiation with 1 Gy relative to un-
irradiated controls. Shown is mean +/− SEM.
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Repair of a targeted double strand break by homologous recombination. (A) DR-GFP; GFP is
expressed only after homology directed repair. (B) Effect of p53R2 overexpression on
recombination after 48 hours. The cell line K-DR was assessed for GFP expression after
transfection with empty vector alone or with I-SceI expression. The influence of simultaneous
expression of wild type p53R2 or a catalytic mutant of p53R2 (p53R2-CM), respectively, was
analyzed and is represented as fold stimulation of GFP expression. **p53R2 overexpression
stimulated GFP expression significantly; p=0.001. (C) Possible impact of nucleotide pool
availability on repair pathway choice.
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